Mfumo wa ATLAS wa Dawa ya Eluting Cobalt Chromium
A cobalt-chromium utoaji wa stent ya moyo nguvu ya radial ya kudumu na uwezo bora wa kufuatilia, inafaa kwa changamano au kuhesabiwa vidonda vya moyo wakati unahakikisha kurudi kidogo.
The ATLAS Drug Eluting Coronary Stent System is a next-generation cobalt-chromium (CoCr) stent platform coated with a sirolimus formulation (1 µg/mm²) designed to reduce restenosis in patients with coronary artery disease. By combining advanced laser-cutting technology and a clinically proven antiproliferative drug, the ATLAS system delivers durable vessel patency and a high safety profile in both de novo lesions and in-stent restenosis scenarios.
Cobalt-Chromium Alloy (L605) Construction
- Ensures exceptional strength-to-thickness ratio, enabling thinner struts without compromising radial force.
- Exhibits excellent corrosion resistance and biocompatibility for a stable healing environment.
Laser-Cut Stent Design
- Precision machining yields consistent strut geometry, promoting uniform drug distribution and an even healing surface along the vessel wall.
- Enhances stent deliverability, allowing smooth passage through calcified or tortuous coronary segments.
Sirolimus Elution Profile
- 1 µg/mm² of sirolimus is coated onto the stent’s surface, ensuring a sustained, controlled release that minimizes in-stent neointimal growth.
- Controlled drug release aids in rapid endothelialization, lowering the risk of late stent thrombosis.
Radiopaque Pt-Ir Markers
- Platinum-iridium markers at stent edges enable precise visibility under fluoroscopy.
- Facilitates accurate positioning during percutaneous coronary intervention (PCI) procedures.
High-Pressure Capability
interventional cardiologists flexibility to optimize stent expansion based on lesion complexity.
| Vipimo | Maelezo / Thamani |
| Jina la Bidhaa | Atlas Coronary Stent (Cobalt Chromium) |
| Stent Type | Balloon-Expandable Coronary Stent |
| Nyenzo | Cobalt-Chromium Alloy |
| Strut Thickness | ~80 µm (typical) |
| Kubuni | Open-cell or hybrid-cell architecture (depending on exact model) |
| Nominal Pressure (NP) | 9–10 atm |
| Rated Burst Pressure (RBP) | ~14–16 atm |
| Stent Delivery System | Rapid-Exchange (RX) or Over-the-Wire (OTW), typically 140 cm shaft length |
| Utangamano wa Mwongozo | 0.014" |
| Stent Surface | Bare-metal or optional drug-eluting polymer (if applicable) |
| Viashiria | Coronary artery lesion scaffolding, single or multivessel disease, potential usage in small/medium/large vessels |
| Contraindications | Lesions unsuited for balloon-expandable stent therapy (e.g., severely calcified, left main trunk, etc.), or as per physician discretion |
| Kuzaa | Asiyezaa (Ethilini Oksidi) |
| Matumizi Moja | Ndiyo |
| Maisha ya Rafu | 2–3 years (depending on final packaging and polymer, if any) |
| Joto la Uendeshaji | Recommended 15–25 °C for storage |
Misimbo ya Kina ya Kuagiza na Bidhaa kwa Kutegemea Ukubwa
| Stent Diameter (mm) | Stent Length (mm) | Nominal Pressure (atm) | RBP (atm) | Kanuni ya Bidhaa |
| 2.00 | 8 | 9 | 14 | ATLS-CC-2.00x08 |
| 2.00 | 12 | 9 | 14 | ATLS-CC-2.00x12 |
| 2.00 | 15 | 9 | 14 | ATLS-CC-2.00x15 |
| 2.00 | 18 | 10 | 16 | ATLS-CC-2.00x18 |
| 2.00 | 24 | 10 | 16 | ATLS-CC-2.00x24 |
| 2.00 | 28 | 10 | 16 | ATLS-CC-2.00x28 |
| 2.00 | 32 | 10 | 16 | ATLS-CC-2.00x32 |
| 2.00 | 38 | 10 | 16 | ATLS-CC-2.00x38 |
| 2.25 | 8 | 9 | 14 | ATLS-CC-2.25x08 |
| 2.25 | 12 | 9 | 14 | ATLS-CC-2.25x12 |
| 2.25 | 15 | 9 | 14 | ATLS-CC-2.25x15 |
| 2.25 | 18 | 10 | 16 | ATLS-CC-2.25x18 |
| 2.25 | 24 | 10 | 16 | ATLS-CC-2.25x24 |
| 2.25 | 28 | 10 | 16 | ATLS-CC-2.25x28 |
| 2.25 | 32 | 10 | 16 | ATLS-CC-2.25x32 |
| 2.25 | 38 | 10 | 16 | ATLS-CC-2.25x38 |
| 2.50 | 8 | 9 | 14 | ATLS-CC-2.50x08 |
| 2.50 | 12 | 9 | 14 | ATLS-CC-2.50x12 |
| 2.50 | 15 | 9 | 14 | ATLS-CC-2.50x15 |
| 2.50 | 18 | 10 | 16 | ATLS-CC-2.50x18 |
| 2.50 | 24 | 10 | 16 | ATLS-CC-2.50x24 |
| 2.50 | 28 | 10 | 16 | ATLS-CC-2.50x28 |
| 2.50 | 32 | 10 | 16 | ATLS-CC-2.50x32 |
| 2.50 | 38 | 10 | 16 | ATLS-CC-2.50x38 |
| 2.75 | 8 | 9 | 14 | ATLS-CC-2.75x08 |
| 2.75 | 12 | 9 | 14 | ATLS-CC-2.75x12 |
| 2.75 | 15 | 9 | 14 | ATLS-CC-2.75x15 |
| 2.75 | 18 | 10 | 16 | ATLS-CC-2.75x18 |
| 2.75 | 24 | 10 | 16 | ATLS-CC-2.75x24 |
| 2.75 | 28 | 10 | 16 | ATLS-CC-2.75x28 |
| 2.75 | 32 | 10 | 16 | ATLS-CC-2.75x32 |
| 2.75 | 38 | 10 | 16 | ATLS-CC-2.75x38 |
| 3.00 | 8 | 9 | 14 | ATLS-CC-3.00x08 |
| 3.00 | 12 | 9 | 14 | ATLS-CC-3.00x12 |
| 3.00 | 15 | 9 | 14 | ATLS-CC-3.00x15 |
| 3.00 | 18 | 10 | 16 | ATLS-CC-3.00x18 |
| 3.00 | 24 | 10 | 16 | ATLS-CC-3.00x24 |
| 3.00 | 28 | 10 | 16 | ATLS-CC-3.00x28 |
| 3.00 | 32 | 10 | 16 | ATLS-CC-3.00x32 |
| 3.00 | 38 | 10 | 16 | ATLS-CC-3.00x38 |
| 3.25 | 12 | 9 | 14 | ATLS-CC-3.25x12 |
| 3.25 | 15 | 9 | 14 | ATLS-CC-3.25x15 |
| 3.25 | 18 | 10 | 16 | ATLS-CC-3.25x18 |
| 3.25 | 24 | 10 | 16 | ATLS-CC-3.25x24 |
| 3.25 | 28 | 10 | 16 | ATLS-CC-3.25x28 |
| 3.25 | 32 | 10 | 16 | ATLS-CC-3.25x32 |
| 3.25 | 38 | 10 | 16 | ATLS-CC-3.25x38 |
| 3.50 | 8 | 9 | 14 | ATLS-CC-3.50x08 |
| 3.50 | 12 | 9 | 14 | ATLS-CC-3.50x12 |
| 3.50 | 15 | 9 | 14 | ATLS-CC-3.50x15 |
| 3.50 | 18 | 10 | 16 | ATLS-CC-3.50x18 |
| 3.50 | 24 | 10 | 16 | ATLS-CC-3.50x24 |
| 3.50 | 28 | 10 | 16 | ATLS-CC-3.50x28 |
| 3.50 | 32 | 10 | 16 | ATLS-CC-3.50x32 |
| 3.50 | 38 | 10 | 16 | ATLS-CC-3.50x38 |
| 4.00 | 8 | 9 | 14 | ATLS-CC-4.00x08 |
| 4.00 | 12 | 9 | 14 | ATLS-CC-4.00x12 |
| 4.00 | 15 | 9 | 14 | ATLS-CC-4.00x15 |
| 4.00 | 18 | 10 | 16 | ATLS-CC-4.00x18 |
| 4.00 | 24 | 10 | 16 | ATLS-CC-4.00x24 |
| 4.00 | 28 | 10 | 16 | ATLS-CC-4.00x28 |
| 4.00 | 32 | 10 | 16 | ATLS-CC-4.00x32 |
| 4.00 | 38 | 10 | 16 | ATLS-CC-4.00x38 |
Bidhaa zinazohusiana
-

SteerCATH Catheter inayoweza kudhibitiwa
Soma zaidiA inayoongoza msaada wa catheter na inayoweza kugeuzwa ncha, iliyoundwa kwa ajili ya tata au chombo cha tawi upatikanaji katika afua za moyo na pembeni. Huongeza mafanikio ya kuvuka katika anatomia zenye changamoto.
-

Extender PTCA Katheta ya Puto
Soma zaidiA kiwango shinikizo la juu puto ya moyo iliyoundwa kwa ajili ya utayarishaji wa vidonda au kujitegemea angioplasty, kutoa wasifu sahihi wa mfumuko wa bei na wasifu uliopunguzwa wa kuvuka.
-

Extender Dawa Eluting PTCA Puto Catheter Paclitaxel
Soma zaidiA paclitaxel-coated katheta ya puto ya moyo inayolenga kupunguza restenosis wakati wa percutaneous transluminal coronary angioplasty (PTCA), kuhakikisha utoaji wa madawa ya kulevya kwa ukuta wa chombo.
-

Mfumo wa Kuondoa Uongozi wa Hero LASER
Soma zaidiA msingi wa laser kuwezesha kifaa cha uchimbaji sahihi na salama kuondolewa kwa inaongoza kwa moyo (pacemaker au ICD) katika visa vya maambukizi, utendakazi wa risasi, au uboreshaji.
